跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 54,461 条关于
“New Brunswick Extra-Mural Program”
全部
54,461
临床试验
24,468
药物
931
机构
423
资讯
28,639
去年
Canada Launches First Home-Based Cancer Immunotherapy Trial Using Subcutaneous Injection
去年
Mural Therapeutics Discontinues Nemvaleukin Program and Cuts 90% of Workforce Following Clinical Setback
去年
Mural Oncology Highlights Nemvaleukin Progress and IL-18 Program at Investor Day
去年
Mural Oncology's Nemvaleukin Trials Progressing, Data Readouts Anticipated in 2025
去年
Mural Oncology Cuts 90% of Workforce Following Failed Cancer Immunotherapy Trials
9个月前
XOMA Royalty Completes $2.035 Per Share Acquisition of Mural Oncology
去年
ICON Partners with Mural Health to Enhance Clinical Trial Patient Experience
去年
XOMA Royalty Acquires Mural Oncology for $36.2 Million in Strategic Biotech Consolidation
去年
Mural Oncology Gears Up for Key Data Readouts of Nemvaleukin in Ovarian Cancer and Melanoma in 2025
去年
ICON and Mural Health Partner to Streamline Clinical Trial Participant Experience with Digital Payment Platform
第 1 页，共 2864 页
上一页
下一页
